Cargando…
Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease with a poor prognosis and unknown aetiology. We have recently clarified the prognostic value of the serum platelet-derived growth factor (PDGF) level in patients with IPF. Interleukin (IL)-11 is a member of the IL-6 family, a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992571/ https://www.ncbi.nlm.nih.gov/pubmed/36910057 http://dx.doi.org/10.21037/jtd-22-876 |
_version_ | 1784902341003051008 |
---|---|
author | Arai, Toru Hirose, Masaki Kagawa, Tomoko Hatsuda, Kazuyoshi Inoue, Yoshikazu |
author_facet | Arai, Toru Hirose, Masaki Kagawa, Tomoko Hatsuda, Kazuyoshi Inoue, Yoshikazu |
author_sort | Arai, Toru |
collection | PubMed |
description | BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease with a poor prognosis and unknown aetiology. We have recently clarified the prognostic value of the serum platelet-derived growth factor (PDGF) level in patients with IPF. Interleukin (IL)-11 is a member of the IL-6 family, and in vivo and in vitro studies have suggested that it has profibrotic effects in pulmonary fibrosis. In this study, we investigated the predictive value of the serum IL-11 level in patients with IPF for survival and occurrence of acute exacerbation (AE). METHODS: This retrospective study included 68 patients with IPF diagnosed according to the 2018 guideline. Serum PDGF levels were measured using the Bio-Plex method and serum IL-11 levels using enzyme-linked immune-sorbent assay. Cytokine production per lung volume was evaluated using the serum cytokine/percent predicted forced vital capacity (%FVC) value. RESULTS: Forty-six patients were male and the median age was 67 years. The serum IL-11/%FVC value was significantly correlated with the percent predicted diffusing capacity of carbon monoxide (ρ=−0.518, P<0.001) and modified Medical Research Council score for shortness of breath (mMRC) (ρ=0.335, P=0.006) by Spearman’s rank correlation analysis. Multivariate Cox proportional hazard regression analysis revealed that the serum IL-11/%FVC value was a significant prognostic factor after adjustment for the serum PDGF/%FVC value and other clinical parameters including mMRC and lymphocyte percentage in bronchoalveolar lavage [hazard ratio (HR): 88.540, 95% confidence interval (CI): 1.905–4,115.686, P=0.022]. IL-11/%FVC value was also a significant predictor of AE after adjustment for age and PDGF/%FVC (HR: 1,815.443, 95% CI: 10.49–314,109.219, P=0.004). CONCLUSIONS: The serum IL-11/%FVC value was an independent predictor of prognosis and AE occurrence in patients with IPF, and the IL-11 level appeared to show pathophysiologic value in IPF. |
format | Online Article Text |
id | pubmed-9992571 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-99925712023-03-09 Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation Arai, Toru Hirose, Masaki Kagawa, Tomoko Hatsuda, Kazuyoshi Inoue, Yoshikazu J Thorac Dis Original Article BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease with a poor prognosis and unknown aetiology. We have recently clarified the prognostic value of the serum platelet-derived growth factor (PDGF) level in patients with IPF. Interleukin (IL)-11 is a member of the IL-6 family, and in vivo and in vitro studies have suggested that it has profibrotic effects in pulmonary fibrosis. In this study, we investigated the predictive value of the serum IL-11 level in patients with IPF for survival and occurrence of acute exacerbation (AE). METHODS: This retrospective study included 68 patients with IPF diagnosed according to the 2018 guideline. Serum PDGF levels were measured using the Bio-Plex method and serum IL-11 levels using enzyme-linked immune-sorbent assay. Cytokine production per lung volume was evaluated using the serum cytokine/percent predicted forced vital capacity (%FVC) value. RESULTS: Forty-six patients were male and the median age was 67 years. The serum IL-11/%FVC value was significantly correlated with the percent predicted diffusing capacity of carbon monoxide (ρ=−0.518, P<0.001) and modified Medical Research Council score for shortness of breath (mMRC) (ρ=0.335, P=0.006) by Spearman’s rank correlation analysis. Multivariate Cox proportional hazard regression analysis revealed that the serum IL-11/%FVC value was a significant prognostic factor after adjustment for the serum PDGF/%FVC value and other clinical parameters including mMRC and lymphocyte percentage in bronchoalveolar lavage [hazard ratio (HR): 88.540, 95% confidence interval (CI): 1.905–4,115.686, P=0.022]. IL-11/%FVC value was also a significant predictor of AE after adjustment for age and PDGF/%FVC (HR: 1,815.443, 95% CI: 10.49–314,109.219, P=0.004). CONCLUSIONS: The serum IL-11/%FVC value was an independent predictor of prognosis and AE occurrence in patients with IPF, and the IL-11 level appeared to show pathophysiologic value in IPF. AME Publishing Company 2023-01-10 2023-02-28 /pmc/articles/PMC9992571/ /pubmed/36910057 http://dx.doi.org/10.21037/jtd-22-876 Text en 2023 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Arai, Toru Hirose, Masaki Kagawa, Tomoko Hatsuda, Kazuyoshi Inoue, Yoshikazu Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation |
title | Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation |
title_full | Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation |
title_fullStr | Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation |
title_full_unstemmed | Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation |
title_short | Interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation |
title_sort | interleukin-11 in idiopathic pulmonary fibrosis: predictive value of prognosis and acute exacerbation |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992571/ https://www.ncbi.nlm.nih.gov/pubmed/36910057 http://dx.doi.org/10.21037/jtd-22-876 |
work_keys_str_mv | AT araitoru interleukin11inidiopathicpulmonaryfibrosispredictivevalueofprognosisandacuteexacerbation AT hirosemasaki interleukin11inidiopathicpulmonaryfibrosispredictivevalueofprognosisandacuteexacerbation AT kagawatomoko interleukin11inidiopathicpulmonaryfibrosispredictivevalueofprognosisandacuteexacerbation AT hatsudakazuyoshi interleukin11inidiopathicpulmonaryfibrosispredictivevalueofprognosisandacuteexacerbation AT inoueyoshikazu interleukin11inidiopathicpulmonaryfibrosispredictivevalueofprognosisandacuteexacerbation |